Public/other = Other financings of public companies, including loans, bridge financings, exercises of warrants, debt offerings, rights offerings, standard private placements, PIPE financings and institutional offerings of registered stock
Company Amount Raised Ironwood Pharmaceuticals Inc. $175M OPKO Health Inc. $175M Mesoblast Ltd. $174.6M Pacira Pharmaceuticals Inc. $110M e-Therapeutics plc $62.66M
Has life changed, since transforming into a public company...Xanthopoulos said the change hasn't been dramatic since the company thrusted itself into the highly regulated world that governs public companies
By Peter Winter | BioWorld Today | Friday, April 19, 2013
Public/other = Other financings of public companies, including loans, bridge financings, exercises of warrants, debt offerings, rights offerings, standard private placements, PIPE financings and institutional offerings of registered stock
The $3.25 billion raised by these public companies was 33 percent higher than the $2.5 billion total raised in the same period of 2012...With the strong after-market performance for public companies that have completed financings, the momentum for the sector should continue into the second quarter
By Peter Winter | BioWorld Insight | Monday, April 8, 2013
Company Amount Raised Ironwood Pharmaceuticals Inc. $175M OPKO Health Inc. $175M Mesoblast Ltd. $174.6M Pacira Pharmaceuticals Inc. $110M e-Therapeutics plc $62.66M
The $3.25 billion raised by these public companies was 33 percent higher than the $2.5 billion total raised in the same period of 2012...With the strong after-market performance for public companies that have completed financings, the momentum for the sector should continue into the second quarter
By Peter Winter | BioWorld Today | Monday, April 8, 2013
SEC OKs Use of Social Media It's OK for public companies to get social when disclosing key information to shareholders, the SEC has decided, as long as they don't play favorites
By Mari Serebrov | BioWorld Today | Thursday, April 4, 2013
The placement stands neck-and-neck with the top private financings of public companies in 2013 to date, with Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) and OPKO Health Inc. (NYSE:OPK), slightly in the lead, each having raised $175 million
By Nuala Moran | BioWorld Today | Friday, March 8, 2013
Public/other = Other financings of public companies, including loans, bridge financings, exercises of warrants, debt offerings, rights offerings, standard private placements, PIPE financings and institutional offerings of registered stock
We think we're an attractive profile, ultimately, for a public company